Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia.

Animals Humans Mice Brain / metabolism Interneurons / metabolism Mice, Knockout Receptors, N-Methyl-D-Aspartate / metabolism Schizophrenia / metabolism
GluN2D NMDA receptor NMDAR antagonists schizophrenia

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Jul 2023
Historique:
received: 12 05 2023
revised: 19 07 2023
accepted: 22 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Glutamate

Identifiants

DOI: 10.3390/ijms241411835 PMID: 37511595 PMC: PMC10380280
pubmed: 37511595
pii: ijms241411835
doi: 10.3390/ijms241411835
pmc: PMC10380280
pii:
doi:

Substances chimiques

NR2D NMDA receptor 0
Receptors, N-Methyl-D-Aspartate 0
Grin2d protein, mouse 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Health and Medical Research Council
ID : 2000893

Références

PLoS One. 2010 Jun 29;5(6):e11351
pubmed: 20613869
JAMA Psychiatry. 2020 Feb 1;77(2):201-210
pubmed: 31664453
Biol Psychiatry. 2000 Oct 1;48(7):627-40
pubmed: 11032974
J Neurosci. 2007 Oct 24;27(43):11496-500
pubmed: 17959792
Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Arch Gen Psychiatry. 2007 Jun;64(6):633-47
pubmed: 17548746
Biol Psychiatry. 2006 Apr 15;59(8):747-53
pubmed: 16476413
Arch Dis Child. 1998 Jan;78(1):1-3
pubmed: 9534666
Arch Gen Psychiatry. 1999 Sep;56(9):781-7
pubmed: 12884883
Schizophr Res. 2022 May;243:98-109
pubmed: 35247795
J Neurosci. 2000 Jun 15;20(12):RC81
pubmed: 10827202
Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):E3007-E3016
pubmed: 29531088
Front Cell Neurosci. 2018 Oct 11;12:354
pubmed: 30364232
Arch Int Pharmacodyn Ther. 1966 Apr;160(2):492-4
pubmed: 5954044
Br J Pharmacol. 2014 Feb;171(3):799-809
pubmed: 24236947
J Neurosci. 2016 May 4;36(18):4976-92
pubmed: 27147651
Transl Psychiatry. 2016 Apr 19;6:e784
pubmed: 27093066
J Comp Neurol. 1994 Sep 1;347(1):150-60
pubmed: 7798379
AMA Arch Gen Psychiatry. 1959 Dec;1:651-6
pubmed: 14438905
J Neurosci. 2002 Apr 15;22(8):3070-80
pubmed: 11943810
Neuron. 2018 Jun 27;98(6):1080-1098
pubmed: 29953871
Compr Psychiatry. 1960 Dec;1:345-8
pubmed: 13694346
J Neurosci. 1993 Dec;13(12):5009-28
pubmed: 8254358
J Physiol. 2004 Jul 15;558(Pt 2):451-63
pubmed: 15146049
Can Psychiatr Assoc J. 1967 Apr;12(2):209-12
pubmed: 6040448
Nat Rev Neurosci. 2013 Jun;14(6):383-400
pubmed: 23686171
J Physiol. 2016 Oct 1;594(19):5471-90
pubmed: 26918438
J Physiol. 2014 May 15;592(10):2059-78
pubmed: 24614743
Neuropsychopharmacology. 2022 Feb;47(3):628-640
pubmed: 34588607
Am J Psychiatry. 2005 Jan;162(1):12-24
pubmed: 15625195
J Affect Disord. 2013 Sep 25;150(3):1019-24
pubmed: 23742829
Front Psychiatry. 2014 May 19;5:47
pubmed: 24904434
Schizophr Bull. 2014 Mar;40 Suppl 2:S107-16
pubmed: 24375459
Dialogues Clin Neurosci. 2010;12(3):345-57
pubmed: 20954430
Neuropharmacology. 2012 Mar;62(3):1574-83
pubmed: 21277876
Front Behav Neurosci. 2019 Feb 26;13:8
pubmed: 30863289
Life (Basel). 2021 Sep 22;11(10):
pubmed: 34685369
Brain Res. 1999 Oct 2;843(1-2):171-83
pubmed: 10528123
Psychiatr Genet. 2005 Sep;15(3):215-21
pubmed: 16094258
Nat Rev Neurosci. 2013 Mar;14(3):202-16
pubmed: 23385869
Cereb Cortex. 2014 Apr;24(4):859-72
pubmed: 23203979
Sci Rep. 2019 Feb 27;9(1):2952
pubmed: 30814558
Brain Res Mol Brain Res. 1995 Oct;33(1):61-71
pubmed: 8774946
Neuron. 2010 Nov 4;68(3):557-69
pubmed: 21040854
Hillside J Clin Psychiatry. 1987;9(1):12-35
pubmed: 2820854
Nat Rev Neurosci. 2010 Feb;11(2):100-13
pubmed: 20087360
Brain Res Bull. 2010 Sep 30;83(3-4):108-21
pubmed: 20417696
Nat Neurosci. 2010 Jan;13(1):76-83
pubmed: 19915563
Nat Commun. 2017 Dec 8;8(1):2015
pubmed: 29222517
Mol Pharmacol. 1996 Dec;50(6):1680-8
pubmed: 8967993
Biol Psychol. 2016 Apr;116:57-67
pubmed: 26549579
PLoS One. 2010 Oct 28;5(10):e13722
pubmed: 21060893
Cell. 1999 Aug 20;98(4):427-36
pubmed: 10481908
Brain Res. 2020 Jan 15;1727:146571
pubmed: 31786200
Mol Psychiatry. 2018 May;23(5):1287-1292
pubmed: 28115737
Lancet. 2009 Jan 3;373(9657):31-41
pubmed: 19058842
J Neurosci. 2020 Sep 30;40(40):7668-7687
pubmed: 32859716
Am J Psychiatry. 1997 Jun;154(6):805-11
pubmed: 9167508
Neurosci Lett. 2016 Jan 1;610:48-53
pubmed: 26520463
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Nov;5(11):1040-1051
pubmed: 32653578
Eur Arch Psychiatry Clin Neurosci. 2010 Mar;260(2):101-11
pubmed: 19856012
Eur J Neurosci. 2001 Jul;14(1):153-60
pubmed: 11488959
Neurosci Biobehav Rev. 2011 Jan;35(3):848-70
pubmed: 20951727
Genes Brain Behav. 2009 Oct;8(7):661-75
pubmed: 19563516
Front Cell Neurosci. 2013 Mar 27;7:31
pubmed: 23543703
J Physiol. 2008 Jan 1;586(1):227-45
pubmed: 17962328
J Neurosci. 2014 Aug 27;34(35):11534-48
pubmed: 25164652
J Neurophysiol. 1998 Feb;79(2):555-66
pubmed: 9463421
Am J Psychiatry. 1962 Jul;119:61-7
pubmed: 14467063
Neuropsychopharmacology. 1998 Jan;18(1):18-25
pubmed: 9408915
Nature. 2022 Apr;604(7906):502-508
pubmed: 35396580
Curr Biol. 2016 Jun 20;26(12):1513-1521
pubmed: 27238283
Neuropharmacology. 2020 Sep 1;174:108136
pubmed: 32474027
Nature. 1976 Jun 24;261(5562):717-9
pubmed: 945467
Lancet Psychiatry. 2018 Aug;5(8):664-677
pubmed: 29602739
J Neurosci. 1996 Jan;16(1):19-30
pubmed: 8613785
J Neurosci. 2003 Feb 15;23(4):1151-8
pubmed: 12598603
Cereb Cortex. 2014 Dec;24(12):3116-30
pubmed: 23825317
PLoS One. 2009 Aug 25;4(8):e6755
pubmed: 19707548
Transl Psychiatry. 2018 Jan 10;8(1):12
pubmed: 29317596
Science. 2008 Apr 25;320(5875):539-43
pubmed: 18369103
PLoS One. 2020 Jun 4;15(6):e0233895
pubmed: 32497062
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Pharmacol Ther. 2020 Jan;205:107426
pubmed: 31629007
Mol Pharmacol. 2016 Dec;90(6):689-702
pubmed: 27625038
Am J Psychiatry. 1991 Oct;148(10):1301-8
pubmed: 1654746
Eur J Paediatr Neurol. 2020 Jan;24:89-99
pubmed: 31918992
Front Hum Neurosci. 2012 Jan 13;5:190
pubmed: 22319485
Adv Pharmacol. 2016;76:351-82
pubmed: 27288082
Schizophr Res. 2017 Oct;188:118-124
pubmed: 28109667
J Neurochem. 1996 Mar;66(3):1240-8
pubmed: 8769890
Brain Res. 1998 Mar 23;787(2):181-90
pubmed: 9518601
Am J Psychiatry. 2016 Nov 1;173(11):1131-1139
pubmed: 27444795
Mol Psychiatry. 2013 Nov;18(11):1185-92
pubmed: 23070074
J Neurosci. 2009 Mar 4;29(9):2774-9
pubmed: 19261873
Int J Biol Sci. 2013 Sep 22;9(9):948-59
pubmed: 24155668
Int J Neuropsychopharmacol. 2014 Nov;17(11):1895-904
pubmed: 24964190
J Neural Transm (Vienna). 2019 Dec;126(12):1637-1651
pubmed: 31529297
J Neurosci. 2019 May 8;39(19):3611-3626
pubmed: 30846615
Am J Psychiatry. 2017 Nov 1;174(11):1102-1111
pubmed: 28945119
Mol Psychiatry. 2023 Jan 23;:
pubmed: 36690793
J Comp Neurol. 1998 Jan 5;390(1):75-90
pubmed: 9456177
PLoS Med. 2005 May;2(5):e141
pubmed: 15916472
Neuroimage Clin. 2020;28:102492
pubmed: 33395983
Int J Endocrinol. 2018 Jan 31;2018:7231915
pubmed: 29666640
Schizophr Bull. 2017 Sep 1;43(5):1056-1063
pubmed: 28338769
Brain Res Mol Brain Res. 1996 Nov;42(1):89-102
pubmed: 8915584
J Neurochem. 1996 Dec;67(6):2335-45
pubmed: 8931465
Neuropsychopharmacology. 1995 Aug;13(1):9-19
pubmed: 8526975
Curr Top Med Chem. 2016;16(29):3385-3403
pubmed: 27291902
Curr Opin Psychiatry. 2012 Mar;25(2):96-102
pubmed: 22297716
Pharmacol Rev. 2010 Sep;62(3):405-96
pubmed: 20716669
Cereb Cortex. 2016 Aug;26(8):3637-3654
pubmed: 27282393
J Psychopharmacol. 2019 Dec;33(12):1588-1599
pubmed: 31580222
J Physiol. 1998 Jul 1;510 ( Pt 1):1-18
pubmed: 9625862
J Neurosci. 2006 May 24;26(21):5825-34
pubmed: 16723541
Mov Disord. 2010 Jun 15;25(8):1068-76
pubmed: 20222137
Neuron. 1994 Mar;12(3):529-40
pubmed: 7512349
Neuropsychopharmacology. 2000 Apr;22(4):400-12
pubmed: 10700659
J Pharmacol Exp Ther. 2016 Mar;356(3):702-11
pubmed: 26675679
Mol Brain. 2013 Dec 16;6:56
pubmed: 24330819
Compr Psychiatry. 2022 May;115:152307
pubmed: 35303585
Psychopharmacology (Berl). 2008 Oct;200(2):217-30
pubmed: 18597079
Nat Neurosci. 2016 Nov;19(11):1442-1453
pubmed: 27668389
Front Neural Circuits. 2010 Aug 06;4:
pubmed: 20844601
Science. 2010 Aug 20;329(5994):959-64
pubmed: 20724638
J Neurosci. 2020 May 13;40(20):3949-3968
pubmed: 32277042
Curr Opin Neurobiol. 2001 Jun;11(3):327-35
pubmed: 11399431
Mol Pharmacol. 1998 Mar;53(3):429-37
pubmed: 9495808
AMA Arch Neurol Psychiatry. 1959 Mar;81(3):363-9
pubmed: 13626287
Br J Pharmacol. 2019 Oct;176(20):4002-4018
pubmed: 31347694
Brain Res Mol Brain Res. 1999 Jan 8;63(2):375-9
pubmed: 9878838
J Neurosci. 1997 Apr 15;17(8):2921-7
pubmed: 9092613
Biochem Biophys Res Commun. 1992 Jun 30;185(3):826-32
pubmed: 1352681
Transl Psychiatry. 2016 Apr 12;6:e778
pubmed: 27070406
J Psychopharmacol. 2013 Nov;27(11):972-86
pubmed: 23863924
Neuropharmacology. 2018 Nov;142:30-40
pubmed: 29885421
Nat Rev Dis Primers. 2015 Nov 12;1:15067
pubmed: 27189524
J Neural Transm (Vienna). 2014 Aug;121(8):799-817
pubmed: 24578174
Cell Rep. 2022 Jun 14;39(11):110948
pubmed: 35705055
Biol Psychiatry. 2015 Jun 15;77(12):1001-9
pubmed: 25676489
Int J Psychiatry Clin Pract. 2018 Sep;22(3):170-176
pubmed: 29069946
Nature. 2005 Nov 10;438(7065):185-92
pubmed: 16281028
Schizophr Res. 2015 Sep;167(1-3):98-107
pubmed: 25583246
Biol Psychiatry. 2023 Aug 15;94(4):297-309
pubmed: 37004850
Front Cell Neurosci. 2017 Nov 07;11:353
pubmed: 29163060
Biomol Ther (Seoul). 2012 Jan;20(1):1-18
pubmed: 24116269
Front Cell Neurosci. 2015 Mar 25;9:95
pubmed: 25859181
Front Psychiatry. 2019 Sep 06;10:584
pubmed: 31551821
NPJ Schizophr. 2015;1:14001
pubmed: 26878032
J Neurophysiol. 2016 Jan 1;115(1):271-85
pubmed: 26510761
Science. 1992 May 22;256(5060):1217-21
pubmed: 1350383
Aust N Z J Psychiatry. 2014 Feb;48(2):169-82
pubmed: 24097844
Neurosci Lett. 1980 Dec;20(3):379-82
pubmed: 6108541
JAMA Psychiatry. 2013 Oct;70(10):1057-66
pubmed: 23966023
J Neurosci. 2015 Dec 2;35(48):15971-83
pubmed: 26631477
Annu Rev Neurosci. 2012;35:203-25
pubmed: 22443509
Arch Gen Psychiatry. 2003 Jun;60(6):572-6
pubmed: 12796220
Front Cell Neurosci. 2015 May 29;9:210
pubmed: 26074777
Front Psychiatry. 2019 Nov 21;10:835
pubmed: 31824347
Eur Neuropsychopharmacol. 2023 Mar;68:57-77
pubmed: 36640734
Neuron. 2012 Aug 23;75(4):556-71
pubmed: 22920249
Mol Psychiatry. 2006 Aug;11(8):737-47, 705
pubmed: 16702973
Neurochem Res. 2019 Jan;44(1):61-77
pubmed: 29651654
Schizophr Bull. 1994;20(1):203-14
pubmed: 8197416
CNS Neurosci Ther. 2013 Jun;19(6):437-47
pubmed: 23611295
J Neurosci. 2012 Sep 12;32(37):12726-34
pubmed: 22972996
NPJ Schizophr. 2015 Oct 28;1:15037
pubmed: 27336043
Neuropharmacology. 2021 Dec 15;201:108833
pubmed: 34637787
Mol Brain. 2017 Apr 26;10(1):15
pubmed: 28446243
J Biol Chem. 1993 Feb 5;268(4):2836-43
pubmed: 8428958
Neuroimage Clin. 2014 Mar 20;4:531-9
pubmed: 24749063
Neuropsychopharmacology. 2008 Aug;33(9):2175-86
pubmed: 18033238
J Neurosci. 2002 Mar 15;22(6):2335-42
pubmed: 11896172
J Neurosci. 1996 Jun 1;16(11):3549-58
pubmed: 8642401
Mol Pharmacol. 2007 Oct;72(4):907-20
pubmed: 17622578
Arch Gen Psychiatry. 2010 Mar;67(3):231-9
pubmed: 20194823
Neuron. 2008 Sep 25;59(6):846-60
pubmed: 18817726
Schizophr Res. 2012 Jun;138(1):1-7
pubmed: 22542616
J Physiol. 2005 Nov 15;569(Pt 1):209-21
pubmed: 16141268
Schizophr Bull. 2018 Oct 17;44(6):1301-1311
pubmed: 29301039
Neuroscience. 2002;114(3):769-79
pubmed: 12220577
Arch Gen Psychiatry. 1994 Mar;51(3):199-214
pubmed: 8122957
J Clin Psychiatry. 2016 Jun;77(6):764-71
pubmed: 27135986
Isr J Psychiatry Relat Sci. 2010;47(1):4-16
pubmed: 20686195
Science. 2014 May 30;344(6187):992-7
pubmed: 24876489
Nat Rev Neurosci. 2017 Dec;18(12):727-740
pubmed: 29070826
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Int J Neuropsychopharmacol. 2019 Jul 1;22(7):449-452
pubmed: 31135879
Arch Gen Psychiatry. 2001 Apr;58(4):361-7
pubmed: 11296097
Early Interv Psychiatry. 2022 May;16(5):481-491
pubmed: 34278723
Br J Pharmacol. 1983 Jun;79(2):565-75
pubmed: 6317114
Proc Natl Acad Sci U S A. 1990 Mar;87(6):2354-8
pubmed: 1690430
Brain Res Mol Brain Res. 1992 Aug;14(4):363-8
pubmed: 1382178
Biol Psychiatry. 2011 Oct 1;70(7):646-54
pubmed: 21549355
Neuron. 2013 Apr 10;78(1):81-93
pubmed: 23583108
Physiol Rep. 2018 Aug;6(16):e13782
pubmed: 30155997
J Neurosci. 2003 Jun 15;23(12):4958-66
pubmed: 12832518
Eur Neuropsychopharmacol. 2015 Aug;25(8):1136-46
pubmed: 26123243
Pharmacol Rev. 2021 Oct;73(4):298-487
pubmed: 34753794
Biol Psychiatry. 2013 Jul 15;74(2):106-12
pubmed: 23312565
Schizophr Bull. 2019 Jan 1;45(1):138-147
pubmed: 29394409
World J Psychiatry. 2021 Jul 19;11(7):355-364
pubmed: 34327128
Nat Med. 2018 Jun;24(6):792-801
pubmed: 29808008
Brain Res Dev Brain Res. 2001 Apr 30;127(2):123-33
pubmed: 11334999
Cereb Cortex. 2008 Nov;18(11):2560-73
pubmed: 18296432
PLoS One. 2012;7(1):e29630
pubmed: 22253750
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8467-72
pubmed: 15159546
Eur Neuropsychopharmacol. 1997 Feb;7(1):9-24
pubmed: 9088881
BMC Neurosci. 2009 Jul 20;10:85
pubmed: 19619324
Biol Psychiatry. 2015 Jun 15;77(12):1031-40
pubmed: 25863358
J Mol Neurosci. 1998 Oct;11(2):121-6
pubmed: 10096038

Auteurs

Chitra Vinnakota (C)

Department of Psychiatry, School of Clinical Sciences, Faculty of Medical, Nursing and Health Sciences, Monash University, Clayton, VIC 3168, Australia.

Matthew R Hudson (MR)

Department of Neuroscience, Faculty of Medical, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia.

Nigel C Jones (NC)

Department of Neuroscience, Faculty of Medical, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia.
ORCID: 0000-0002-1080-8439

Suresh Sundram (S)

Department of Psychiatry, School of Clinical Sciences, Faculty of Medical, Nursing and Health Sciences, Monash University, Clayton, VIC 3168, Australia.
Mental Health Program, Monash Health, Clayton, VIC 3168, Australia.
ORCID: 0000-0002-9674-0227

Rachel A Hill (RA)

Department of Psychiatry, School of Clinical Sciences, Faculty of Medical, Nursing and Health Sciences, Monash University, Clayton, VIC 3168, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Potential Roles for the GluN2D NMDA Receptor...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Potential Roles for the GluN2D NMDA Receptor...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Potential Roles for the GluN2D NMDA Receptor...
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Potential Roles for the GluN2D NMDA Receptor...
questionsmedicales.fr › Cellules › Neurones › Interneurones › Potential Roles for the GluN2D NMDA Receptor...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Souris knockout › Potential Roles for the GluN2D NMDA Receptor...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux neuromédiateurs › Récepteurs aux acides aminés › Récepteurs au glutamate › Récepteurs ionotropes du glutamate › Récepteurs du N-méthyl-D-aspartate › Potential Roles for the GluN2D NMDA Receptor...
questionsmedicales.fr › Troubles mentaux › Schizophrénie et troubles avec traits psychotiques › Schizophrénie › Potential Roles for the GluN2D NMDA Receptor...